Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Avidity Biosciences (RNA) Return on Equity (2020 - 2025)

Historic Return on Equity for Avidity Biosciences (RNA) over the last 6 years, with Q3 2025 value amounting to 0.36%.

  • Avidity Biosciences' Return on Equity fell 1500.0% to 0.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36%, marking a year-over-year decrease of 1500.0%. This contributed to the annual value of 0.33% for FY2024, which is 600.0% up from last year.
  • According to the latest figures from Q3 2025, Avidity Biosciences' Return on Equity is 0.36%, which was down 1500.0% from 0.36% recorded in Q2 2025.
  • In the past 5 years, Avidity Biosciences' Return on Equity registered a high of 0.21% during Q3 2024, and its lowest value of 0.43% during Q3 2022.
  • Moreover, its 5-year median value for Return on Equity was 0.34% (2022), whereas its average is 0.32%.
  • Its Return on Equity has fluctuated over the past 5 years, first tumbled by -1700bps in 2021, then surged by 2000bps in 2024.
  • Avidity Biosciences' Return on Equity (Quarter) stood at 0.3% in 2021, then fell by -20bps to 0.36% in 2022, then decreased by -14bps to 0.42% in 2023, then soared by 47bps to 0.22% in 2024, then plummeted by -62bps to 0.36% in 2025.
  • Its last three reported values are 0.36% in Q3 2025, 0.36% for Q2 2025, and 0.27% during Q1 2025.